REGENXBIO

EUIPO EUIPO 2014 Trademark registered

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark REGENXBIO was filed as Word mark on 10/01/2014 at the European Union Intellectual Property Office.
It was registered as a trademark on 02/24/2015. The current status of the mark is "Trademark registered".

Trademark Details Last update: June 25, 2024

Trademark form Word mark
File reference 013315403
Application date October 1, 2014
Publication date November 17, 2014
Entry date February 24, 2015
Expiration date October 1, 2034

Trademark owner

9804 Medical Center Drive
20850 Rockville
US

Trademark representatives

23/31 boulevard Romain Rolland 75014 PARIS FR

goods and services

42 Custom development of biochemical reagents, namely, synthesis for others of clinical medical reagents for use in gene therapy, development of pharmaceutical preparations for use in gene therapy, and therapeutic compositions that include recombinant adeno-associated viral (rAAV) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy, RNA interference (RNAi), and cell therapy; Scientific and medical research and development; Genetic engineering services, biotechnology services, and research and development of new products in the field of gene therapeutics and research tools, including those based on recombinant adeno-associated viral vectors

Trademark history

Date Document number Area Entry
June 24, 2024 Extension, Trade mark renewed
April 16, 2024 Change Representative, Published
August 17, 2022 Change Representative, Published
June 28, 2021 Transfer / Change of address, Published
January 8, 2020 Transfer / Change of address, Published
May 15, 2015 Transfer / Change of address, Published

ID: 11013315403